Mirae Asset Global Investments
PLRX icon

Mirae Asset Global Investments’s Pliant Therapeutics PLRX Stock Holding History

Mirae Asset Global Investments’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,373
Closed -$3.51K – 1721
2025
Q3 		$3.51K Buy
2,373
+2
+0.1% +$3 ﹤0.01% 1622
2025
Q2 		$2.75K Buy
2,371
+335
+16% +$473 ﹤0.01% 1558
2025
Q1 		$2.99K Buy
2,036
+8
+0.4% +$49 ﹤0.01% 1528
2024
Q4 		$27.5K Sell
2,028
-171
-8% -$2.33K ﹤0.01% 1376
2024
Q3 		$24.9K Buy
2,199
+398
+22% +$4.98K ﹤0.01% 1404
2024
Q2 		$19.2K Buy
+1,801
New +$23.2K ﹤0.01% 1383
2024
Q1 		– Sell
-27,363
Closed -$496K – 2601
2023
Q4 		$496K Buy
27,363
+89
+0.3% +$1.35K ﹤0.01% 1971
2023
Q3 		$473K Buy
27,274
+69
+0.3% +$1.2K ﹤0.01% 1916
2023
Q2 		$493K Buy
+27,205
New +$644K ﹤0.01% 1953

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Mirae Asset Global Investments's PLRX Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Pliant Therapeutics (PLRX) in Q4 2025, closing a stake of 2,373 shares — an estimated $3.51K sold.

Mirae Asset Global Investments first reported a position in PLRX in Q2 2023 and held it in 9 quarters. The position peaked at $496K in Q4 2023. 96 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining Pliant Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,373 Pliant Therapeutics shares in Q4 2025, an estimated $3.51K.
  • Mirae Asset Global Investments first reported a position in Pliant Therapeutics in Q2 2023 and held it in 9 quarters.
  • Mirae Asset Global Investments's Pliant Therapeutics position peaked at $496K in Q4 2023.
  • 96 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.